The present invention relates to mirabegron and process of its preparation. The present invention provides the process of preparation of amorphous form or crystalline form of mirabegron. The present invention also provide a pharmaceutical composition comprising amorphous mirabegron substantially free from crystalline form. The present invention also relates to a a pharmaceutical composition comprising crystalline mirabegron.